Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125212421 | 12521242 | 1 | I | 20160623 | 20160701 | 20160701 | EXP | PHHY2016US087393 | SANDOZ | PARSONS KA, DERKITS ME. VISUAL HALLUCINATIONS ASSOCIATED WITH GABAPENTIN USE. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(10):631-34 | 65.00 | YR | F | Y | 71.00000 | KG | 20160701 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125212421 | 12521242 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, FOUR TIMES A DAY AND ALSO 600 MG QD AT BED TIME | Y | 75539 | 1800 | MG | QID | ||||||
| 125212421 | 12521242 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, QD | Y | 75539 | 300 | MG | QD | ||||||
| 125212421 | 12521242 | 3 | C | INSULIN ASPART | INSULIN ASPART | 1 | Unknown | U | 0 | ||||||||||
| 125212421 | 12521242 | 4 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 50 MG, BID | U | 0 | 50 | MG | BID | ||||||
| 125212421 | 12521242 | 5 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 125212421 | 12521242 | 6 | C | WARFARIN | WARFARIN | 1 | Oral | 5?10 MG | U | 0 | QD | ||||||||
| 125212421 | 12521242 | 7 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 125212421 | 12521242 | 8 | C | TERIPARATIDE | TERIPARATIDE | 1 | Subcutaneous | 20 UG, QD | U | 0 | 20 | UG | QD | ||||||
| 125212421 | 12521242 | 9 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 100 MG, QD | U | 0 | 100 | MG | EXTENDED RELEASE TABLET | QD | |||||
| 125212421 | 12521242 | 10 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 30 MG, QD | U | 0 | 30 | MG | QD | ||||||
| 125212421 | 12521242 | 11 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Unknown | 20 MG, BID | U | 0 | 20 | MG | BID | ||||||
| 125212421 | 12521242 | 12 | C | MULTIPLE VITAMINS | VITAMINS | 1 | Oral | U | 0 | ||||||||||
| 125212421 | 12521242 | 13 | C | LINOLEIC ACID | LINOLEIC ACID | 1 | Unknown | Y | 0 | ||||||||||
| 125212421 | 12521242 | 14 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125212421 | 12521242 | 1 | Neuralgia |
| 125212421 | 12521242 | 3 | Product used for unknown indication |
| 125212421 | 12521242 | 4 | Product used for unknown indication |
| 125212421 | 12521242 | 5 | Product used for unknown indication |
| 125212421 | 12521242 | 6 | Product used for unknown indication |
| 125212421 | 12521242 | 7 | Product used for unknown indication |
| 125212421 | 12521242 | 8 | Product used for unknown indication |
| 125212421 | 12521242 | 9 | Product used for unknown indication |
| 125212421 | 12521242 | 10 | Product used for unknown indication |
| 125212421 | 12521242 | 11 | Product used for unknown indication |
| 125212421 | 12521242 | 12 | Product used for unknown indication |
| 125212421 | 12521242 | 13 | Product used for unknown indication |
| 125212421 | 12521242 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125212421 | 12521242 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125212421 | 12521242 | Fatigue | |
| 125212421 | 12521242 | Hallucination, visual | |
| 125212421 | 12521242 | Incorrect dose administered | |
| 125212421 | 12521242 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |